The Ethics of Placebos in AIDS Drug Trials
Porter, John D.H.
Forrest, Bruce D.
Kennedy, Ann R.
HEC (HealthCare Ethics Committee) Forum. 1992; 4(3): 155-162.
Conclusion: Rather than lamenting over the impending demise of the placebo-control trial, scientists should be concentrating on developing methodology for making better use of postlicensing surveillance. Through ethical reflection and the way forward, a society changes its vision. Mankind is ingenious and thrives on change and challenge. The epidemiology of AIDS clinical trials needs to move forward to encompass the ethical and moral changes facing our society today. Mental energy and imagination should be directed at new methods for investigating drugs and other medications which will benefit the entire population.
Aids; Clinical Trials; Codes of Ethics; Common Good; Control Groups; Drugs; Discrimination; Epidemiology; Ethics; Guidelines; HIV Seropositivity; Human Experimentation; Justice; Methods; Moral Policy; Placebos; Random Selection; Research; Research Design; Research Subjects; Risks and Benefits; Social Discrimination; Terminally Ill; Therapeutic Research;
Showing items related by title, author, creator and subject.
Porter, John D.H.; Forrest, Bruce D.; Kennedy, Ann R. (1992)
Ahmad, Khabir (2005-06)
Barinaga, Marcia (1988-10-06)